| Title |
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets
|
|---|---|
| Published in |
OncoTargets and therapy, January 2021
|
| DOI | 10.2147/ott.s242248 |
| Pubmed ID | |
| Authors |
Nico C Grossmann, Victor M Schuettfort, Benjamin Pradere, Marco Moschini, Fahad Quhal, Hadi Mostafaei, Francesco Soria, Satoshi Katayama, Ekaterina Laukhtina, Keiichiro Mori, Reza Sari Motlagh, Cédric Poyet, Mohammad Abufaraj, Pierre I Karakiewicz, Shahrokh F Shariat, David D’Andrea |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 25% |
| Austria | 2 | 25% |
| Saudi Arabia | 1 | 13% |
| Unknown | 3 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 75% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 15 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 3 | 20% |
| Student > Bachelor | 3 | 20% |
| Researcher | 2 | 13% |
| Student > Doctoral Student | 1 | 7% |
| Professor | 1 | 7% |
| Other | 1 | 7% |
| Unknown | 4 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 40% |
| Veterinary Science and Veterinary Medicine | 2 | 13% |
| Biochemistry, Genetics and Molecular Biology | 1 | 7% |
| Business, Management and Accounting | 1 | 7% |
| Neuroscience | 1 | 7% |
| Other | 0 | 0% |
| Unknown | 4 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 January 2021.
All research outputs
#7,337,336
of 25,584,565 outputs
Outputs from OncoTargets and therapy
#377
of 2,967 outputs
Outputs of similar age
#171,552
of 524,561 outputs
Outputs of similar age from OncoTargets and therapy
#12
of 95 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 2,967 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 524,561 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.